Structure Therapeutics Inc. American Depositary Shares
Symbol: GPCR (NASDAQ)
26.09
▲ (12.31%) 2.860
Company Description:
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Key Stats
- Today's Open: $23.22
- Today's High: $26.225
- Today's Low: $21.8
- Today's Volume: 1.01M
- Yesterday Close: $23.23
- Yesterday High: $23.47
- Yesterday Low: $21.8332
- Yesterday Volume: 788.43K
- Last Min Volume: 337
- Last Min High: $26.09
- Last Min Low: $26.09
- Last Min VWAP: $26.09
Company Profile
- Name: Structure Therapeutics Inc. American Depositary Shares
- Website: https://www.structuretx.com
- Listed Date: 2023-02-03
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001888886
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.36B
- Round Lot: 100
- Outstanding Shares: 57.60M
- Asset Type: ADRC
RECENT FILINGS FOR GPCR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-18 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-06 | S-3ASR | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-01 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |